is the fda banning tirzepatide US judge sides with FDA's removal of Lilly's weight loss drug from shortage list 🚨 Important Update on Compounded

Serious but Rare Risks GLP-1 medications can aggravate or trigger severe pancreatic inflammation in some patients. Both oral and injectable GLP-1 medications may cause gallbladder disease, and in rare cases involving patients with relevant risk factors, there have been associations with thyroid changes observed in animal studies. A serious allergic reaction is possible but uncommon

Your first week is part of the tolerability ramp, not a preview of the full maintenance experience

Dual agonism outperforms single agonism

Some signs of a B12 deficiency include fatigue, headaches, pale or yellow skin, and difficulty concentrating